Endra Life Sciences Inc (NDRA)

[apollo1452]

My .02 on the brutal pps pullback the past 3 weeks.

Primarily a retail investor base but that will evolve next 1-6 months.

Growing pains with timelines that were too ambitious, PRs that're technically correct but not for retail consumption.

Shorts have been tenacious. Despite some covering last 2 reports still 11.74%, today's daily short volume 60.32% smh. Their aggressiveness overwhelmed the bid support last 3 weeks.

Recall on 9/26/19 the stock price was up 3% pre market on the TAEUS top line data release & yes the data was good.
Soon after the opening bell an orchestrated naked short attack trashed the stock & the losing streak has continued.

Francois gets a mulligan with the complete, peer reviewed data release from Robarts Research Institute this month. It will be interesting to see if Robarts explains the complete data better than the NDRA pr explained the top line info.

Also keep in mind at the investor conferences Francois talked about the peer reviewed data release IN OCTOBER from Robarts, NOT the top line data released in Spain.

So, interested investors from those conferences would be waiting for the Robarts data, not the Spain top line data that retail is obsessed with.